Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwMyeloma 2015 | Prospective targeted therapies for multiple myeloma

At the Myeloma 2015 meeting, Prof Philippe Moreau (Centre Hospitalier Universitaire de Nantes, France) describes clinical studies of new treatments for multiple myeloma (MM) that are expected to publish results in the upcoming month. These studies include elotuzumab in combination with lenalidomide and dexamethasone for relapsed MM, daratumumab for advanced MM and carfilzomib for relapsed MM.